
AVAH Stock Forecast & Price Target
AVAH Analyst Ratings
Bulls say
Aveanna Healthcare Holdings Inc. reported a revenue rate of $495.43, reflecting a 0.6% increase, with a gross margin growth of 32.6%, exceeding expectations due to improved administrative cost management. The company achieved strong performances across its segments, notably in Private Duty Services, which saw revenue growth of 25.6% to $514.4 million, and Home Health & Hospice, which grew 15.3% year-over-year to $62.4 million, driven by significant increases in admissions. Additionally, the firm has improved cash flow and financial flexibility, raising its revenue guidance to above $2.375 billion, indicating confidence in ongoing operational execution and strategic initiatives.
Bears say
The analysis of Aveanna Healthcare Holdings Inc. indicates several fundamental challenges contributing to a negative outlook for the company's stock. Key concerns include potential reimbursement pressures, high leverage, increased competition, and continued labor headwinds, which are projected to drive a 10% downside to the base case FY26 adjusted EBITDA estimate. Furthermore, while the company reported better-than-expected revenue of $45.1 million, the gross margin declined to 45.0%, raising questions about profitability amidst operational hurdles and regulatory issues.
This aggregate rating is based on analysts' research of Aveanna Healthcare Holdings and is not a guaranteed prediction by Public.com or investment advice.
AVAH Analyst Forecast & Price Prediction
Start investing in AVAH
Order type
Buy in
Order amount
Est. shares
0 shares